Definitive Contract W81XWH20C0071
Award Date
9/23/20
Potential Completion Date
1/22/23
Potential Value
$962K
Federal Agency
Medical Command
Awardee
Inbios International Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the U.S. Army Medical Command (MEDCOM), is for a Small Business Innovation Research (SBIR) Phase II project, valued at $891,867.91. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the ultimate completion date is January 14, 2020. Inbios International Inc. is a specialized manufacturer of...
This federal contract award, W81XWH15P0522, was made by the U.S. Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $95,000.00 firm fixed-price purchase order contract was set aside for small businesses and has an ultimate completion date of October 15, 2015. The contract is for NORO-RD products, which likely refers to diagnostic devices or related medical technology. Inbios International is a critical...
This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...
This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the Medical Command (MEDCOM) agency of the U.S. Department of Defense, is for ICT (Information and Communications Technology) development on a Cost-Plus-Fixed-Fee (CPFF) basis. The contract has a ceiling value of $1,724,742.02 and an ultimate completion date of September 18, 2019. The contract is not set-aside and was awarded...
This federal contract award, valued at $5,508,014.60, was issued by the Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for Information and Communications Technology (ICT) Development on a Cost-Plus-Fixed-Fee (CPFF) basis, with a completion date of July 20, 2019. Inbios, a Subchapter S Corporation, is a manufacturer of immunodiagnostic devices for infectious diseases. This contract award...
This is a $25,655,995.03 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the development of COVID-19 antigen detection tests and optimization of serology assays as part of the FDA's Fast Track program. The contract has a period of performance through May 31, 2025. Inbios International Inc. has a history of providing critical testing products...
This is a $12,670,301.06 firm fixed-price definitive contract awarded by the U.S. Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Authority (BARDA) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the production capacity expansion of COVID-19 diagnostic tests and was awarded under Contracting Opportunity FA7013-20-S-0002, which did not have a set-aside designation....
This federal contract award, valued at $4,708.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the procurement of "TEST KIT,VISCERAL L" and has a completion date of June 24, 2024. Inbios International Inc. is a veteran-owned, for-profit organization that specializes in the design, development, and manufacture of immunodiagnostic...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Contracting Command (ACC) Aberdeen Proving Ground to Nowdiagnostics, Inc., a self-certified small disadvantaged business. The $1,999,257.92 firm-fixed-price contract is for research and development work related to rapid diagnostic testing solutions, particularly in the field of medical diagnostics. Nowdiagnostics previously participated as a sub-awardee on federal research grants, demonstrating its...